Symptom clusters in newly diagnosed glioma patients: Which symptom clusters are independently associated with functioning and global health status?

Marijke B. Coomans*, Linda Dirven, Neil K. Aaronson, Brigitta G. Baumert, Martin Van Den Bent, Andrew Bottomley, Alba A. Brandes, Olivier Chinot, Corneel Coens, Thierry Gorlia, Ulrich Herrlinger, Florence Keime-Guibert, Annika Malmström, Francesca Martinelli, Roger Stupp, Andrea Talacchi, Michael Weller, Wolfgang Wick, Jaap C. Reijneveld, Martin J.B. Taphoorn

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Background: Symptom management in glioma patients remains challenging, as patients suffer from various concurrently occurring symptoms. This study aimed to identify symptom clusters and examine the association between these symptom clusters and patients' functioning. Methods: Data of the CODAGLIO project was used, including individual patient data from previously published international randomized controlled trials (RCTs) in glioma patients. Symptom prevalence and level of functioning were assessed with European Organisation for Research and Treatment of Cancer (EORTC) quality of life QLQ-C30 and QLQ-BN20 self-report questionnaires. Associations between symptoms were examined with Spearman correlation coefficients and partial correlation networks. Hierarchical cluster analyses were performed to identify symptom clusters. Multivariable regression analyses were performed to determine independent associations between the symptom clusters and functioning, adjusted for possible confounders. Results: Included in the analysis were 4307 newly diagnosed glioma patients from 11 RCTs who completed the EORTC questionnaires before randomization. Many patients (44%) suffered from 5-10 symptoms simultaneously. Four symptom clusters were identified: a motor cluster, a fatigue cluster, a pain cluster, and a gastrointestinal/seizures/bladder control cluster. Having symptoms in the motor cluster was associated with decreased (≥10 points difference) physical, role, and social functioning (betas ranged from-11.3 to-15.9, all P < 0.001), independent of other factors. Similarly, having symptoms in the fatigue cluster was found to negatively influence role functioning (beta of-12.3, P < 0.001), independent of other factors. Conclusions: Two symptom clusters, the fatigue and motor cluster, were frequently affected in glioma patients and were found to independently have a negative association with certain aspects of patients' functioning as measured with a self-report questionnaire.

Original languageEnglish
Pages (from-to)1447-1457
Number of pages11
JournalNeuro-Oncology
Volume21
Issue number11
DOIs
Publication statusPublished - 4 Nov 2019

Cite this

Coomans, M. B., Dirven, L., Aaronson, N. K., Baumert, B. G., Van Den Bent, M., Bottomley, A., ... Taphoorn, M. J. B. (2019). Symptom clusters in newly diagnosed glioma patients: Which symptom clusters are independently associated with functioning and global health status? Neuro-Oncology, 21(11), 1447-1457. https://doi.org/10.1093/neuonc/noz118